Jade Biosciences, Inc. (JBIO) › Operating IncomeJade Biosciences, Inc. (JBIO) — Operating IncomeAnnual figures by period end, from SEC filings.2020-12-31: -$8.89M2021-12-31: -$23.02M2022-12-31: -$53.24M2023-12-31: -$81.41M2024-12-31: -$74.60M2025-12-31: -$113.54M-$113.54M2020-12-31Operating Income (USD)2025-12-31Period endedOperating IncomeChange YoYSource filing2025-12-31-$113.54M—2026-03-06From 2025-01-012024-12-31-$74.60M—2025-03-27From 2024-01-012023-12-31-$81.41M—2025-03-27From 2023-01-012022-12-31-$53.24M—2024-03-25From 2022-01-012021-12-31-$23.02M—2023-03-29From 2021-01-012020-12-31-$8.89M—2022-03-30From 2020-01-01Other metrics: RevenueCost of RevenueGross ProfitNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per ShareWeighted Average Diluted SharesEPS (Basic)